Journal ArticleDOI
Classic Interstitial Cystitis: Unrelated to BPS
Magnus Fall,Ralph Peeker +1 more
TLDR
Recent progress in the understanding of the BPS/IC complex will be discussed, emphasizing the fact that the classic Hunner disease (BPS type 3C according to the European Society for the Study of Interstitial Cystitis (ESSIC) classification) is a well-defined condition that fulfills the requirements of the denomination interstitial cystitis.Citations
More filters
Journal ArticleDOI
Interstitial Cystitis/Bladder Pain Syndrome.
TL;DR: The exact longitudinal course by which peripheral and central aberrations involving the bladder mucosa, peripheral inflammation, and central dysregulation of bladder sensitivity create painful bladder symptoms remains an area in need of further study as mentioned in this paper.
Journal ArticleDOI
Role of cystoscopy and hydrodistention in the diagnosis of interstitial cystitis/bladder pain syndrome.
Gisela Ens,Gustavo Garrido +1 more
TL;DR: The recommendations of various societies and associations of greater impact in this complex disease are reviewed, analyzing the indications, technique, findings and complications of this procedure.
Journal ArticleDOI
Women's Experiences of Interstitial Cystitis/Painful Bladder Syndrome.
TL;DR: In this article, a phenomenological approach with emphasis on reflection and openness was adopted to explore the lived experience of interstitial cystitis (IC)/painful bladder syndrome (PBS).
Journal ArticleDOI
A New Approach to Urologic Chronic Pelvic Pain Syndromes: Applying Oncologic Principles to “Benign” Conditions
TL;DR: The urologic chronic pelvic pain syndromes (UCPPS) continue to be both a major cause of morbidity in patients and huge challenge to clinicians as discussed by the authors, due to patients having common symptoms but differing underlying pain mechanisms.
References
More filters
Journal ArticleDOI
Diagnostic Criteria, Classification, and Nomenclature for Painful Bladder Syndrome/Interstitial Cystitis: An ESSIC Proposal
Joop P. van de Merwe,Jørgen Nordling,Pierre Bouchelouche,Kirsten Bouchelouche,Mauro Cervigni,L. Kurosch Daha,Suzy Elneil,Magnus Fall,Gero Hohlbrugger,Paul P. Irwin,S. A. Mortensen,Arndt van Ophoven,John L. Osborne,Ralph Peeker,Benedikte Richter,Claus R. Riedl,Jukka Sairanen,Martina Tinzl,Jean-Jacques Wyndaele +18 more
TL;DR: The name IC has become misleading and is replaced by BPS, in line with recent nomenclature recommendations by the European Association of Urology and based on the axial structure of the International Association for the Study of Pain classification.
Journal ArticleDOI
Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987
Jay Y. Gillenwater,Alan J. Wein +1 more
Journal ArticleDOI
The interstitial cystitis symptom index and problem index
TL;DR: Both indices should be useful in the evaluation and management of patients with IC and should be particularly useful in clinical trials of new therapies for this condition, where reliable, validated, and reproducible outcome measures are critically important.
Journal ArticleDOI
Prevalence of Symptoms of Bladder Pain Syndrome/Interstitial Cystitis Among Adult Females in the United States
Sandra H. Berry,Marc N. Elliott,Marika J. Suttorp,Laura M. Bogart,Laura M. Bogart,Michael A. Stoto,Paul W. Eggers,Leroy M. Nyberg,J. Quentin Clemens,J. Quentin Clemens +9 more
TL;DR: It is suggested that bladder pain syndrome/interstitial cystitis symptoms are widespread among United States women and associated with considerable disability, and underdiagnosed, and this first population based symptom prevalence estimate is provided.
Journal ArticleDOI
Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies.
Anne-Marie Irani,Timothy R. Bradford,Christopher L. Kepley,Norman M. Schechter,Lawrence B. Schwartz +4 more
TL;DR: An improved immunohistochemical technique for distinguishing human mast cells of the MCT and MCTC types utilizing a biotinylated murine anti-chymase monoclonal antibody (MAb), termed B7, and an alkaline phosphatase-conjugated murines anti-tryptase MAb, termed G3 is developed.
Related Papers (5)
Hunner lesion disease differs in diagnosis, treatment and outcome from bladder pain syndrome: an ESSIC working group report
Magnus Fall,Jørgen Nordling,Mauro Cervigni,Paulo Dinis Oliveira,Jennifer Yonaitis Fariello,Philip M. Hanno,Christina Kåbjörn-Gustafsson,Yr Logadottir,Jane Meijlink,Nagendra Mishra,Robert M. Moldwin,Loredana Nasta,Jörgen Quaghebeur,Vicki Ratner,Jukka Sairanen,Rajesh Taneja,Hikaru Tomoe,Tomohiro Ueda,Gjertrud Wennevik,Kristene Whitmore,Jean-Jacques Wyndaele,Andrew Zaitcev +21 more